XML 52 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
Derivative Instruments
9 Months Ended
Sep. 30, 2012
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments
Derivative Instruments
Risk Management Objective of Using Derivatives
The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risk, including interest rate, liquidity and credit risk primarily by managing the amount, sources and duration of its debt funding and, to a limited extent, the use of derivative instruments.
The Company has entered into derivative instruments to manage exposures that arise from business activities that result in the payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company's derivative instruments, described below, are used to manage differences in the amount, timing and duration of the Company's known or expected cash payments principally related to certain of the Company's borrowings.
Cash Flow Hedges of Interest Rate Risk
The Company's objective in using interest rate derivatives is to manage its exposure to interest rate movements and add stability to interest expense. To accomplish this objective, the Company uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreement without exchange of the underlying notional amount.
The Company utilizes four interest rate swaps to hedge the variable cash flows associated with variable-rate debt. The effective portion of changes in the fair value of derivatives that are designated and that qualify as cash flow hedges is recorded in "Accumulated other comprehensive income" and is subsequently reclassified into earnings in the period that the hedged forecasted transaction affects earnings. The ineffective portion of the change in fair value of the derivatives is recognized directly in earnings.
In July 2012, the Company entered into an interest rate swap with a notional amount of $300,000 that terminates on February 24, 2016, the maturity date of the Company's unsecured term loan (see Note 11). The swap was determined to be effective on July 31, 2012 and effectively converts one-month floating rate LIBOR into a fixed rate of 0.53875% on $300,000 of the Company's LIBOR-based debt over the term of the swap. As of September 30, 2012, the fair value of the Company’s $300,000 interest rate swap was a liability of $1,247, which is included in "Other liabilities" in the condensed consolidated balance sheets.
Amounts reported in "Accumulated other comprehensive income" related to derivatives will be reclassified to interest expense as interest payments are made on the Company's variable-rate debt. Over the next 12 months, the Company estimates that an additional $1,987 will be reclassified as an increase to interest expense.
The Company had the following outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk:
 
 
Number of Instruments
 
Notional
Interest Rate Derivatives
 
September 30,
2012
 
December 31,
2011
 
September 30,
2012
 
December 31,
2011
Interest Rate Swap
 
4

 
3

 
$
376,109

 
$
76,269


The table below presents the estimated fair value of the Company's derivative financial instruments as well as their classification in the condensed consolidated balance sheets. The valuation techniques utilized are described in Note 15 to the condensed consolidated financial statements.
 
Liability Derivatives
 
September 30, 2012
 
December 31, 2011
 
Balance Sheet Location
 
Fair
Value
 
Balance Sheet
Location
 
Fair
Value
Derivatives designated as cash flow hedges:
 
 
 
 
 
 
 
Interest rate swaps
Other Liabilities
 
$
3,482

 
Other Liabilities
 
$
2,891


The table below presents the effect of the Company's derivative financial instruments in the condensed consolidated statements of operations and other comprehensive loss.
Derivatives in
Cash Flow Hedging
Relationships
 
Amount of Loss
Recognized in OCI
on Derivative
(Effective Portion)
 
Location of Loss
Reclassified from
Accumulated OCI
into Income
(Effective Portion)
 
Amount of Loss
Reclassified from
Accumulated OCI
into Income
(Effective Portion)
 
Location of Loss
Recognized In
Income on Derivative
(Ineffective Portion and Amount Excluded from
Effectiveness Testing)
 
Amount of Loss
Recognized in Income on
Derivative
(Ineffective Portion and
Amount Excluded from
Effectiveness Testing and
Missed Forecasted
Transactions)
Interest Rate Swaps
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
2012
 
$
1,430

 
$
1,629

 
Interest Expense
 
$
449

 
$
1,038

 
Other Expense
 
$
157

 
$
467

2011
 
$
419

 
$
1,289

 
Interest Expense
 
$
279

 
$
2,260

 
Other Expense
 
$
148

 
$
157


Credit-risk-related Contingent Features
Derivative financial investments expose the Company to credit risk in the event of non-performance by the counterparties under the terms of the interest rate hedge agreements. The Company believes it minimizes credit risk by transacting with major creditworthy financial institutions. As part of the Company's ongoing control procedures, it monitors the credit ratings of counterparties and the exposure to any single entity, which minimizes credit risk concentration. The Company believes the potential impact of realized losses from counterparty non-performance is not significant.
The Company has agreements with each of its derivative counterparties that contain a provision whereby if the Company defaults on the related indebtedness, including default where repayment of the indebtedness has not been accelerated by the lender, then the Company could also be declared in default on its corresponding derivative obligation. The Company was not in default with respect to these agreements at September 30, 2012.
The Company's agreements with each of its derivative counterparties also contain a provision whereby if the Company consolidates with, merges with or into, or transfers all or substantially all of its assets to another entity and the creditworthiness of the resulting, surviving or transferee entity is materially weaker than the Company's, the counterparty has the right to terminate the derivative obligations. As of September 30, 2012, the termination value of derivatives in a liability position, which includes accrued interest of $142 but excludes any adjustment for non-performance risk, which the Company has deemed not significant, was $3,671. As of September 30, 2012, the Company has not posted any collateral related to these agreements. If the Company had breached any of these provisions at September 30, 2012, it could have been required to settle its obligations under the agreements at their termination value of $3,671.